Fulgent genetics, inc. (FLGT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15
Revenue

34,911

32,528

29,814

25,092

22,068

21,351

19,959

18,837

18,077

18,730

0

0

0

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

18,276

15,323

13,217

0

0

0

Cost of revenue

15,196

14,107

13,242

11,969

10,893

10,697

10,473

10,129

9,464

8,551

7,869

7,744

7,276

6,721

7,584

6,359

0

0

0

Gross profit

19,715

18,421

16,572

13,123

11,175

10,654

9,486

8,708

8,613

10,179

12,434

13,067

12,866

11,555

7,739

6,858

0

0

0

Operating expenses:
Research and development

7,091

6,537

6,168

5,862

5,500

5,534

5,432

5,122

4,830

4,223

3,717

4,112

3,848

3,558

6,390

5,178

0

0

0

Selling and marketing

6,223

5,898

5,391

4,819

4,794

4,652

4,604

4,872

4,444

4,205

3,923

3,433

3,059

2,469

3,584

2,971

0

0

0

General and administrative

6,920

6,414

6,061

5,845

5,580

5,538

5,561

5,460

5,234

5,233

4,947

4,889

4,206

4,609

5,449

4,518

0

0

0

Total operating expenses

20,234

18,849

17,620

16,526

15,874

15,724

15,597

15,454

14,508

13,661

12,587

12,434

11,113

10,636

15,423

12,667

0

0

0

Operating loss

-519

-428

-1,048

-3,403

-4,699

-5,070

-6,111

-6,746

-5,895

-3,482

-153

633

1,753

919

-7,684

-5,809

0

0

0

Interest and other income, net

871

837

686

640

546

434

0

0

0

-

-

-

-

-

-

-

-

-

-

Interest and other income, net

-

-

-

-

-

-

-

-

-

481

441

301

-5,281

-5,387

-5,437

-5,442

0

0

0

Loss before income taxes and equity loss in investee

352

409

-362

-2,763

-4,153

-4,636

-5,678

-6,311

-5,438

-3,001

288

934

-3,528

0

0

0

-

-

-

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Provision for income taxes

64

43

969

590

483

36

-1,448

-1,545

-1,555

-1,015

84

916

1,026

920

0

0

0

-

0

Loss before equity loss in investee

288

366

-1,331

-3,353

-4,636

-4,672

-4,230

-4,766

-3,883

-1,986

204

18

0

0

0

-

-

-

-

Income (loss) before equity in net loss of affiliate

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

Equity loss in investee

-747

-777

-837

-872

-969

-935

-948

-910

-769

0

0

0

-

-

-

0

-

-

-

Income (loss) from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,388

-13,440

-11,153

0

0

0

Income (loss) from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

41

-855

-1,676

0

0

0

Net loss

-459

-411

-2,168

-4,225

-5,605

-5,607

-5,178

-5,676

-4,652

-2,510

-73

-87

-4,572

-5,347

-13,497

-12,031

0

0

0

Net loss per common share:
Basic

-0.09

-0.01

0.08

0.02

-0.10

-0.11

-0.03

-0.06

-0.11

-

-

-

-

-

-0.46

-0.66

-0.05

-

-

Diluted

-0.09

-0.01

0.08

0.02

-0.10

-0.11

-0.03

-0.06

-0.11

-

-

-

-

-

-0.46

-0.66

-0.05

-

-

Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

Weighted-average common shares:
Basic

21,566

19,762

18,502

18,344

18,228

-

-

-

-

-

-

-

-

-

25,275

12

12,077

-

-

Diluted

21,566

19,762

18,502

18,344

18,228

-

-

-

-

-

-

-

-

-

25,275

12

12,077

-

-

Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0